GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: ScienceDaily

What happened

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies.

Key facts

  • Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies.
  • Reported by ScienceDaily and published Thu, 24 Sep 2026 03:15:18 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by ScienceDaily. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at ScienceDaily

Related WorldPing coverage

ScienceDaily
WorldPing
ScienceDaily

More REM sleep linked to lower risk of 83 diseases

A large study tracking more than 95,000 people suggests that how you sleep may be linked to your risk of developing dozens of diseases.

Brief by WorldPing · Original reporting by ScienceDaily